| 1. |
Pellikka PA, Dangas G. TAVR for severe aortic regurgitation: advancing the frontier. J Am Coll Cardiol, 2017, 70(22): 2764-2765.
|
| 2. |
Markham R, Ghodsian M, Sharma R. TAVR in patients with pure aortic regurgitation: ready to use?. Curr Cardiol Rep, 2020, 22(9): 98.
|
| 3. |
Mierke J, Winkler A, Mangner N. Complete embolic protection of the cerebral arteries: TAVI despite large left ventricular thrombus. JACC Case Rep, 2020, 2(8): 1103-1105.
|
| 4. |
Blusztein D, Teng P, Deuse T, et al. Shock, thrombus, TAVR: a challenging TAVR with large left-ventricular thrombus. Can J Cardiol. 2021, 37(10): 1668-1670.
|
| 5. |
Deftereos S, Giannopoulos G, Raisakis K, et al. How should I treat a TAVI-eligible patient with a left ventricular thrombus and rapid clinical deterioration?. EuroIntervention, 2017, 12(16): 2033-2036.
|
| 6. |
Bittencourt MS, Achenbach S, Marwan M, et al. Left ventricular thrombus attenuation characterization in cardiac computed tomography angiography. J Cardiovasc Comput Tomogr, 2012, 6(2): 121-126.
|
| 7. |
Camaj A, Fuster V, Giustino G, et al. Left ventricular thrombus following acute myocardial infarction: JACC state-of-the-art review. J Am Coll Cardiol, 2022, 79(10): 1010-1022.
|
| 8. |
Velangi PS, Choo C, Chen KA, et al. Long-term embolic outcomes after detection of left ventricular thrombus by late gadolinium enhancement cardiovascular magnetic resonance imaging: a matched cohort study. Circ Cardiovasc Imaging, 2019, 12(11): e009723.
|
| 9. |
Levine GN, McEvoy JW, Fang JC, et al. Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association. Circulation, 2022, 146(15): e205-e223.
|
| 10. |
Weinsaft JW, Kim RJ, Ross M, et al. Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus. JACC Cardiovasc Imaging, 2009, 2(8): 969-979.
|
| 11. |
Gorog DA. Potentiation of thrombus instability: a contributory mechanism to the effectiveness of antithrombotic medications. J Thromb Thrombolysis, 2018, 45(4): 593-602.
|
| 12. |
Colle B, Demeure F, Higny J, et al. Emerging trends in left ventricular thrombus: a comprehensive review of non-ischemic and ischemic cardiopathies, including eosinophilic myocarditis, chagas cardiomyopathy, amyloidosis, and innovative anticoagulant approaches. Diagnostics (Basel), 2024, 14(9): 948.
|
